238 related articles for article (PubMed ID: 31507612)
1. Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis.
Wardowska A; Komorniczak M; Bułło-Piontecka B; Dȩbska-Ślizień MA; Pikuła M
Front Immunol; 2019; 10():2026. PubMed ID: 31507612
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells' characteristics in patients with treated systemic lupus erythematosus.
Wardowska A; Smoleńska Ż; Lisowska KA; Zdrojewski Z; Pikuła M
Acta Biochim Pol; 2020 Jul; 67(3):417-429. PubMed ID: 32730703
[TBL] [Abstract][Full Text] [Related]
3. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
Tucci M; Quatraro C; Lombardi L; Pellegrino C; Dammacco F; Silvestris F
Arthritis Rheum; 2008 Jan; 58(1):251-62. PubMed ID: 18163476
[TBL] [Abstract][Full Text] [Related]
4. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
5. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data.
Zhang W; Liang G; Zhou H; Zeng X; Zhang Z; Xu X; Lai K
Clin Rheumatol; 2023 May; 42(5):1423-1433. PubMed ID: 36595110
[TBL] [Abstract][Full Text] [Related]
7. Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review.
Tucci M; Ciavarella S; Strippoli S; Dammacco F; Silvestris F
Ann N Y Acad Sci; 2009 Sep; 1173():449-57. PubMed ID: 19758185
[TBL] [Abstract][Full Text] [Related]
8. Biomarker profiling for lupus nephritis.
Li Y; Fang X; Li QZ
Genomics Proteomics Bioinformatics; 2013 Jun; 11(3):158-65. PubMed ID: 23732627
[TBL] [Abstract][Full Text] [Related]
9. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis.
Tucci M; Calvani N; Richards HB; Quatraro C; Silvestris F
Ann N Y Acad Sci; 2005 Jun; 1051():421-32. PubMed ID: 16126984
[TBL] [Abstract][Full Text] [Related]
10. Interferon (IFN)-inducible Absent in Melanoma 2 proteins in the negative regulation of the type I IFN response: Implications for lupus nephritis.
Choubey D; Panchanathan R
Cytokine; 2020 Aug; 132():154682. PubMed ID: 30904426
[TBL] [Abstract][Full Text] [Related]
11. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis.
Fiore N; Castellano G; Blasi A; Capobianco C; Loverre A; Montinaro V; Netti S; Torres D; Manno C; Grandaliano G; Ranieri E; Schena FP; Gesualdo L
Mol Immunol; 2008 Jan; 45(1):259-65. PubMed ID: 17570528
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
Halfon M; Tankeu AT; Ribi C
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
[TBL] [Abstract][Full Text] [Related]
15. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
Gerl V; Lischka A; Panne D; Grossmann P; Berthold R; Hoyer BF; Biesen R; Bruns A; Alexander T; Jacobi A; Dörner T; Burmester GR; Radbruch A; Hiepe F
Ann Rheum Dis; 2010 Jul; 69(7):1370-7. PubMed ID: 19854711
[TBL] [Abstract][Full Text] [Related]
16. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
17. A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis.
Parikh SV; Malvar A; Shapiro J; Turman JM; Song H; Alberton V; Lococo B; Mejia-Vilet JM; Madhavan S; Zhang J; Yu L; Satoskar AA; Birmingham D; Jarjour WN; Rovin BH; Ganesan LP
Front Immunol; 2021; 12():621039. PubMed ID: 33659005
[TBL] [Abstract][Full Text] [Related]
18. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.
Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W
Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679
[TBL] [Abstract][Full Text] [Related]
19. Immune cells and type 1 IFN in urine of SLE patients correlate with immunopathology in the kidney.
Scott E; Dooley MA; Vilen BJ; Clarke SH
Clin Immunol; 2016 Jul; 168():16-24. PubMed ID: 27102764
[TBL] [Abstract][Full Text] [Related]
20. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
